Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 90,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the firm’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $13.06, for a total transaction of $1,175,400.00. Following the sale, the chief executive officer now directly owns 2,273,100 shares of the company’s stock, valued at approximately $29,686,686. The trade was a 3.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC traded up $1.62 during trading on Monday, hitting $13.50. 4,890,529 shares of the company traded hands, compared to its average volume of 1,764,946. The stock has a market capitalization of $2.59 billion, a price-to-earnings ratio of -17.53 and a beta of 1.45. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The business’s fifty day moving average is $11.91 and its 200-day moving average is $10.58.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The firm’s revenue for the quarter was up 51.6% on a year-over-year basis. During the same period last year, the company earned ($0.19) earnings per share. As a group, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on ALHC shares. UBS Group increased their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Barclays increased their target price on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. KeyCorp started coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Stephens restated an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research note on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average price target of $11.38.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently made changes to their positions in ALHC. nVerses Capital LLC acquired a new position in shares of Alignment Healthcare during the third quarter worth approximately $95,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare in the third quarter worth $131,000. Creative Planning increased its holdings in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after purchasing an additional 2,072 shares during the period. Principal Financial Group Inc. raised its stake in shares of Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after purchasing an additional 2,077 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new stake in Alignment Healthcare in the third quarter worth about $315,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.